EUVIMEDEUVIMED entdecken
Crossref

Nifuroxazide protects against diabetic neuropathy in rats by enhancing Nrf2/HO-1 signaling and inhibiting the NF-κB and JAK-1/STAT3 pathways

Omar Babateen

Annals of Clinical and Analytical Medicine · 01.11.2026 · 17 (11) · 1156-1161

DOI: 10.4328/acam.23051 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Analytical Medicine, erschienen am 01.11.2026. Verfasst von Omar Babateen. Die Arbeit nennt 24 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Diabetic neuropathy remains one of the most debilitating complications of diabetes, driven by oxidative stress, chronic inflammation, and neuronal apoptosis. This work explored the protective role of nifuroxazide (NIF), a known signal transducer and activator of transcription 3 (STAT3) inhibitor, in a rat model of streptozotocin-induced peripheral neuropathy.

Methods

Forty male albino rats were divided into four groups: healthy controls, NIF-treated controls, diabetic controls, and diabetic rats receiving NIF. After induction of diabetes and stabilization, NIF was administered orally for four weeks.

Results

Biochemical evaluation revealed that diabetes markedly increased lipid peroxidation and reduced antioxidant enzyme activity, while NIF treatment restored superoxide dismutase and catalase activities and lowered malondialdehyde levels. These antioxidant effects were accompanied by activation of the nuclear factor erythroid 2–related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) pathway. Inflammatory analysis showed that diabetes elevated phosphorylated Janus kinase 2 (JAK2)/STAT3, nuclear factor kappa B (NF-κB), and pro-inflammatory cytokines, whereas NIF significantly suppressed these mediators. Apoptotic markers, including caspase-3 and B-cell lymphoma 2 (Bcl-2)–associated X protein (Bax), were upregulated in diabetic nerves, with a parallel decline in Bcl-2; NIF reversed these changes, indicating anti-apoptotic efficacy. Histological examination further confirmed that NIF preserved sciatic nerve architecture, reducing vacuolation, demyelination, and endoneurial disruption.

Conclusion

Overall, NIF demonstrated a multifaceted neuroprotective effect by attenuating oxidative stress, dampening inflammatory signaling, and preventing apoptosis. These findings suggest that NIF may represent a promising therapeutic candidate for diabetic neuropathy, acting through coordinated modulation of antioxidant, inflammatory, and apoptotic pathways.

Zitieren

APA

Babateen, O. (2026). Nifuroxazide protects against diabetic neuropathy in rats by enhancing Nrf2/HO-1 signaling and inhibiting the NF-κB and JAK-1/STAT3 pathways. Annals of Clinical and Analytical Medicine, 17(11), 1156-1161. https://doi.org/10.4328/acam.23051

Vancouver

Babateen O. Nifuroxazide protects against diabetic neuropathy in rats by enhancing Nrf2/HO-1 signaling and inhibiting the NF-κB and JAK-1/STAT3 pathways. Annals of Clinical and Analytical Medicine. 2026;17(11):1156-1161. doi:10.4328/acam.23051

BibTeX
@article{Babateen2026,
  author = {Babateen, Omar},
  title = {Nifuroxazide protects against diabetic neuropathy in rats by enhancing Nrf2/HO-1 signaling and inhibiting the NF-κB and JAK-1/STAT3 pathways},
  journal = {Annals of Clinical and Analytical Medicine},
  year = {2026},
  volume = {17},
  number = {11},
  pages = {1156--1161},
  doi = {10.4328/acam.23051}
}
Kostenlos starten →